Boston Scientific down 6% on preliminary 2019 revenue [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
Healthcare | On the Move Boston Scientific down 6% on preliminary 2019 revenue Jan. 14, 2020 9:38 AM ET Boston Scientific Corporation (BSX) Mamta Mayani Boston Scientific ( -6.3% reports Q4 revenue is expected to be ~$2.9B, representing growth of ~13.4% on a reported basis, compared to previous guidance range of 13% to 15%. FY 2019 sales of ~$10.74B, growth of ~9.3% on a reported basis, compared to prior guidance of 9% to 9.5%. Q4 and FY 2019 Endoscopy sales of $500M and $1.89B, respectively. Q4 and FY 2019 Urology and Pelvic Health sales of $380M and $1.41B, respectively. Q4 and FY 2019 Rhythm and Neuro sales of $820M and $3.14B, respectively. Q4 and FY 2019 Cardiovascular sales of $1.15B and $4.21B, respectively. Q4 and FY 2019 Specialty Pharmaceuticals of $60M and $80M, respectively. The company estimates that it will exceed its previous EPS guidance of $0.22 to $0.25 for Q4 and $0.72 to $0.75 per share for FY 2019, on a GAAP basis. The company's non-GAAP EPS will be within its pr
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Peripheral Vascular Stent Market is Expected to Reach an Estimated US$ 8,878.00 million by 2034 with a CAGR of 7.60% from 2024 to 2034 | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- iVEAcare Launches with $27.5 Million in Series A Funding from Leading Medtech Investors [Yahoo! Finance]Yahoo! Finance
- Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics [Yahoo! Finance]Yahoo! Finance
- Global Veterinary Ultrasound Research Report 2024: Market to Surpass $500 Million by 2030 - Focus on Improving Livestock Health in Emerging Countries Presents Untapped Growth Opportunities [Yahoo! Finance]Yahoo! Finance
- FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 1/31/24 - Miss
BSX
Sec Filings
- 4/4/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- BSX's page on the SEC website